LaraKRotter retweeted
New in @AnnalsofIMCC: Researchers describe the challenging diagnosis of an atypical presentation of #legionellosis due to nonserogroup-1 L pneumophila. Read full text for free bit.ly/3BSrQKN
@LaraKimR @YaleMedPTSTP @TradIMYale @YaleIMed @MarkSiegel1
Our first session on Intimate Partner Violence for our residents!A series I was inspired to start by our amazing PD @MarkSiegel1.Grateful for the phenomenal teamwork: Ms.Schippiani(CCADV) and Drs.McNamara, Savage&Sharninghausen.Making a difference together!💪@TradIMYale @YaleIMed
Grateful to be part of this incredible group — our expanding force of Physician-Scientists! @YaleMedPSTP @TradIMYale @MarkDSiegel1
Happy Holidays from @YaleMedPSTP !
Cheers to Physician-Scientists!
After our recent study on why many clinical trials end prematurely (xitter.cf/Dr_AmerZeidan/status/1…), we set our focus on Global Disparities in Leukemia Clinical Trials (ascopubs.org/doi/10.1200/GO-…).Thanks to our phenomenal team! @Alhajahjeh_Abd @Dr_AmerZeidan...
@YaleMedPSTP @MarkDSiegel1
Our newest paper co-led by our outstanding @YaleMed resident @LaraKimR & 🇯🇴recent graduate @Alhajahjeh_Abd (applying for #Match2025 so program directors plz pay notice) Analyzing determinants of premature trial discontinuation in leukemia clinical trials tandfonline.com/doi/full/10.…
LaraKRotter retweeted
No words can express how lucky, grateful our trainees have been to have Dr. Marwan Azar as our program director! Will miss him greatly - wishing you all the success on your next career endeavors!! #IDTwitter #MedTwitter
LaraKRotter retweeted
This is a very critical issue for me especially as one of my friend's brothers has recently passed away due to a lack of access to one of the novel leukemia medications that might help him. I'm thankful for the great support of @Dr_AmerZeidan @MaxStahlMD and @LaraKimR
Just in time for #ASH24; our new paper from @YaleCancer @YaleHematology group examined the Global Disparities in Characteristics & Outcomes of Leukemia Clinical Trials, led by rising 🇯🇴 star @Alhajahjeh_Abd We need more trials in developing countries ascopubs.org/doi/10.1200/GO-…
LaraKRotter retweeted
Big thanks to @LaraKimR for her phenomenal work and to @Dr_AmerZeidan for the incredible support all the way!! Very excited for the next😁
Our newest paper co-led by our outstanding @YaleMed resident @LaraKimR & 🇯🇴recent graduate @Alhajahjeh_Abd (applying for #Match2025 so program directors plz pay notice) Analyzing determinants of premature trial discontinuation in leukemia clinical trials tandfonline.com/doi/full/10.…
LaraKRotter retweeted
Our newest paper co-led by our outstanding @YaleMed resident @LaraKimR & 🇯🇴recent graduate @Alhajahjeh_Abd (applying for #Match2025 so program directors plz pay notice) Analyzing determinants of premature trial discontinuation in leukemia clinical trials tandfonline.com/doi/full/10.…
LaraKRotter retweeted
So excited to join @ColumbiaMed! I have focused my career on supporting the next generation in academic med. The Vagelos Institute for Biomedical Research Education will leverage strengths of @Columbia to build the best environment for physician-scientists from UME to faculty!
We’re excited to welcome Dr. Jay Vyas, as our new Assoc. Dean for Academic Innovation & Director of Physician-Scientist Programs at the Vagelos Institute for Basic Biomedical Science. He'll also join the Division of Infectious Diseases in @CUIMCDeptofMed.
columbiamed.link/3YdlLPR
LaraKRotter retweeted
So proud of @TradIMYale PGY3 @LaraKimR making a splash at IDSA! Watch out NIH! @YaleIMed @YaleIDFellows
Replying to @YaleIDFellows
Not one, but TWO Challenging Case presentations by the fabulous Maria Koshy (2nd year fellow) and Lara Rotter @LaraKimR (3rd year IM resident) 2/5
LaraKRotter retweeted
Not one, but TWO Challenging Case presentations by the fabulous Maria Koshy (2nd year fellow) and Lara Rotter @LaraKimR (3rd year IM resident) 2/5
Thrilled to have presented a compelling case at the intersection of transplant ID and critical care! Grateful for the inspiring connections and unwavering support and trust, especially from Dr.Marwan Azar.This opportunity truly means a lot! @YaleIDFellows @YaleMedPSTP @TradIMYale
LaraKRotter retweeted
Pics of our beautiful city, just in time for @TradIMYale interview season. @YaleIMed
The view as autumn colors begin to arrive on campus. 🍂 #Yale
📷: David Liebowitz ’26
LaraKRotter retweeted
Looking forward to seeing you all!
In the sign-up form, you can drop your questions, and we will be happy to answer them during the events.
Join us for one of three webinars starting tonight for Yale Internal Medicine's Traditional Residency Training Program!
@TradIMYale @MarkDSiegel1
Grateful for the opportunity to raise awareness about IPV via @NEJM. IPV is a significant cause of death for women - 1/3 globally, US: 50% female victims killed by current/former partner. IPV is linked to 6% of suicides.
Thank you Lara Rotter @TradIMYale PGY3 for sharing this heartbreaking story. A must read. @TradIMYale @annareisman
nejm.org/doi/full/10.1056/NE…
LaraKRotter retweeted
Thank you Lara Rotter @TradIMYale PGY3 for sharing this heartbreaking story. A must read. @TradIMYale @annareisman
nejm.org/doi/full/10.1056/NE…
LaraKRotter retweeted
I am excited to share that I am starting my lab in NHLBI as a Lasker Clinical Research Scholar with the goal of understanding the pathogenesis and developing therapeutics for patients with infections that cause critical illness. @NIHCritCare @TheBethesdaLabs @Raquel_DaCruz
This Post is from an account that no longer exists. Learn more
LaraKRotter retweeted
A parting shot: these authors suggest in this paper that we spend too much time, teaching modal presentations of diseases, and not enough time teaching the full spectrum of presentations of common diseases, which would have higher utility
amjmed.com/article/S0002-934…































